Implied RALS Analyst Target Price: $43

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares RAFI Long/Short ETF (RALS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $42.60 per unit.

START SLIDESHOW:
10 ETFs With Most Upside To Analyst Targets »

With RALS trading at a recent price near $38.84 per unit, that means that analysts see 9.69% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of RALS's underlying holdings with notable upside to their analyst target prices are PDL BioPharma Inc ( PDLI), Rexnord Corp ( RXN), and PHH Corp ( PHH). Although PDLI has traded at a recent price of $3.18/share, the average analyst target is 17.92% higher at $3.75/share. Similarly, RXN has 17.23% upside from the recent share price of $18.34 if the average analyst target price of $21.50/share is reached, and analysts on average are expecting PHH to reach a target price of $17.00/share, which is 16.68% above the recent price of $14.57. Below is a twelve month price history chart comparing the stock performance of PDLI, RXN, and PHH:

PDLI, RXN, and PHH Relative Performance Chart

Below is a summary table of the current analyst target prices discussed above:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
ProShares RAFI Long/Short ETF RALS $38.84 $42.60 9.69%
PDL BioPharma Inc PDLI $3.18 $3.75 17.92%
Rexnord Corp RXN $18.34 $21.50 17.23%
PHH Corp PHH $14.57 $17.00 16.68%

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

More from Stocks

Abercrombie & Fitch CEO: We Aren't the Same Abercrombie You Once Knew

Abercrombie & Fitch CEO: We Aren't the Same Abercrombie You Once Knew

Amazon Wants to Use Your Car as a Mobile Warehouse - Here's What That Could Mean

Amazon Wants to Use Your Car as a Mobile Warehouse - Here's What That Could Mean

Chipotle's New CEO Has Set its Path for Redemption

Chipotle's New CEO Has Set its Path for Redemption

TheStreet Is About to Hold the BEST Institutional Investor Conference of 2018

TheStreet Is About to Hold the BEST Institutional Investor Conference of 2018

Twitter's Turnaround Continues but Investors Don't Seem Entirely Convinced

Twitter's Turnaround Continues but Investors Don't Seem Entirely Convinced